 
 
Tel: +86-021-3762 1270
Fax: +86-021-6762 1877
Email: service@genicbio.com



| FC131 TFA | {2-Naph-Ala}-{Gly}-{Tyr}-{Arg}-{Arg} | 
| (Arg)9 TFA | RRRRRRRRR | 
| (Glp1)-Apelin-13, human, bovine | Glp-RPRLSHKGPMPF | 
| (Met 210) Melanoctye Protein PMEL 17 (209-217) (human) | IMDQVPFSV | 
| [Ala1,3,11,15]-Endothelin TFA | ASASSLMDKEAVYFAHLDIIW | 
| [Ala9] Autocamtide 2 | KKALRRQEAVDAL | 
| [Arg8]-Vasotocin TFA | Cys-Tyr-Ile-Gln-Asn-Cys-Pro-Arg-Gly-NH2(Disulfide bridge:Cys1-Cys6) | 
| [Asp371]-Tyrosinase (369-377), human | YMDGTMSQV | 
| [bAla8]-Neurokinin A(4-10) | DSFV-{Bal}-LM-NH2 | 
| [Cys8] Renin Substrate Tetradecapeptide, rat | DRVYIHPCHLLYYS | 
| [Des-Arg9]-Bradykinin | RPPGFSPF | 
| [Des-His1,Glu9] Glucagon, amide | SQGTFTSEYSKYLDSRRAQDFVQWLMNT-NH2 | 
| [DPro2,DPhe7,DTrp9] Substance P | R-DPro-KPQQ-DPhe-F-DTrp-LM-NH2 | 
| [DTrp6]-LH-RH, amide | Glp-HWSY-DTrp-LRPG-NH2 | 
| [Gln8]-C517 (LH-RH), chicken | {pGLU}-HWSYGLQPG | 
| [Glu1] Fibrinopeptide B, human | EGVNDNEEGFFSAR | 
| [Leu5]-Enkephalin | YGGFL | 
| [Leu5]-Enkephalin, amide | YGGFL-NH2 | 
| [Leu8] Renin Substrate Tetradecapeptide, rat | DRVYIHPLHLLYYS | 
| [Met5]-Enkephalin, amide | YGGFM-NH2 | 
| [Nle11]-Substance P | RPKPQQFFGL-{NLE}-NH2 | 
| [pSer2, pSer5, pSer7]-CTD | Y-{pSer}-PT-{pSer}-P-{pSer}-YSPTSPSYSPTSPS | 
| [pThr3]-CDK5 Substrate | PK-{pTHR}-PKKAKKL | 
| [pTyr5] EGFR 988-993 | DADE-{pTyr}-L | 
| [Pyr1]-Apelin-13 | {Glp}-RPRLSHKGPMPF | 
| [Sar1, Ile8]-Angiotensin II | {SAR}-RVYIHPI | 
| [Sar9,Met(O2)11]-Substance P | RPKPQQFF-{Sar}-LM[O2]-NH2 | 
| [Sar9] Substance P | RPKPQQFF-{SAR}-LM-NH2 | 
| [SER140]-PLP(139-151) | HSLGKWLGHPDKF | 
| [Thi5,8,DPhe7] Bradykinin | RPPG-Thi-S-DPhe-Thi-R | 
| [Tyr0] Bradykinin | YRPPGFSPFR | 
| [Tyr0] Fibrinopeptide A, human | YADSGEGDFLAEGGGVR | 
| [Tyr38, Phe42,46] Bone Gla Protein | YQEAFRRFFGPV | 
| [Val8] Renin Substrate Tetradecapeptide, rat | DRVYIHPVHLLYYS | 
| {Val1}-Exendin-3/4 | VSKQMEEEAVRLFIEWLKNGGPSSGAPPPS | 
| 26Rfa, Hypothalamic Peptide, human | TSGPLGNLAEELNGYSRKKGGFSFRF-NH2 | 
| 2-Furoyl-LIGRLO-amide | {Fur-2-oyl}-LIGRL-{Orn}-NH2 | 
| 3Flag | DYKDDDDKGDYKDDDDKIDYKDDDDK | 
| 3X FLAG peptide | MDYKDHDGDYKDHDIDYKDDDDK | 
| 5FAM-DEEIYEELK-NH2 | 5FAM-DEEIYEELK-NH2 | 
| 5FAM-ERRKSKSGA-NH2 | 5FAM-ERRKSKSGA-NH2 | 
| 5FAM-NVKSKIGSTENLK-NH2 | 5FAM-NVKSKIGSTENLK-NH2 | 
| 5FAM-QNPSRCSVSLSNVEA-NH2 | 5FAM-QNPSRCSVSLSNVEA-NH2 | 
| 5FAM-RKRRQTSM | 5FAM-RKRRQTSM | 
| 5FAM-RKRSRAEA-NH2 | 5FAM-RKRSRAEA-NH2 | 
| 5FAM-RPRTSSF | 5FAM-RPRTSSF | 
| 5FAM-RQMSFRL | 5FAM-RQMSFRL | 
| 5FAM-RTKRSGSVYEPLKI-NH2 | 5FAM-RTKRSGSVYEPLKI-NH2 | 
| 5-Tamra-DRVYIHP | 5-Tamra-DRVYIHP | 
| Abaloparatide TFA | AVSEHQLLHDKGKSIQDLRRRELLEKLL-{Aib}-KLHTA-NH2 | 
| Abl Cytosolic Substrate | EAIYAAPFAKKK | 
| Abz-FR-K(Dnp)-P-OH | Abz-FR-K(Dnp)-P | 
| Ac2-26 TFA | AMVSEFLKQAWFIENEEQEYVQTVK | 
| Ac-DEVD-AFC | Ac-DEVD-7-amido-4-trifluoroMethylcoumarin | 
| Acetalin-1 | Ac-RFMWMT-NH2 | 
| Acetalin-2 | Ac-RFMWMR-NH2 | 
| Acetalin-3 | Ac-RFMWMK-NH2 | 
| Acetyl Angiotensinogen (1-14), porcine | Ac-DRVYIHPFHLLVYS | 
| Acetyl, Angiotensinogen (1-14), human | Ac-DRVYIHPFHLVIHN | 
| Acetyl-PHF6 amide TFA | Ac-VQIVYK-NH2 | 
| Ac-IEPD-AFC | Ac-IEPD-AFC | 
| Ac-IEVDID (TFA) | Ac-IEVDID | 
| Ac-IEVDIDV (TFA) | Ac-IEVDIDV | 
| Ac-IEVDIDVE (TFA) | Ac-IEVDIDVE | 
| Ac-IEVDIDVEH (TFA) | Ac-IEVDIDVEH | 
| Ac-Leu-Arg-AMC | Ac-Leu-Arg-AMC | 
| Ac-MBP 1-11 | Ac-ASQKRPSQRSK | 
| ACTH (1-10), human | SYSMEHFRWG | 
| ACTH (1-13), human | SYSMEHFRWGKPV | 
| ACTH (1-16), human | SYSMEHFRWGKPVGKK | 
| ACTH (1-17), human | SYSMEHFRWGKPVGKKR | 
| ACTH (1-24), human | SYSMEHFRWGKPVGKKRRPVKVYP | 
| ACTH (1-39), human | SYSMEHFRWGKPVGKKRRPVKVYPNGAEDESAEAFPLEF | 
| ACTH (1-39), rat | SYSMEHFRWGKPVGKKRRPVKVYPNVAENESAEAFPLEF | 
| ACTH (18-39), human | RPVKVYPNGAEDESAEAFPLEF | 
| ACTH (4-10), human | MEHFRWG | 
| ACTH (4-11), human | MEHFRWGK | 
| ACTH (6-24), human | HFRWGKPVGKKRRPVKVYP | 
| ACTH 11-24 | KPVGKKRRPVKVYP | 
| ACTH 1-14 | SYSMEHFRWGKPVG | 
| ACTH 22-39 | VYPNGAEDESAEAFPLEF | 
| ACTH 34-39 | AFPLEF | 
| Activated Protein C (390-404), human | YGVYTKVSRYLDWIH | 
| Ac-VDID (TFA) | Ac-VDID | 
| Acyl Carrier Protein (ACP) 65-74 | VQAAIDYING | 
| Adipokinetic Hormone (AKH) (24-32), locust | Pyr-LNFTPNWGT-NH2 | 
| Adrenomedullin (1-12), human | YRQSMNNFQGLR | 
| Adrenomedullin (11-50), rat | STGCRFGTCTMQKLAHQIYQFTDKDKDGMAP RNKISPQGY-NH2(Disulfide bridge: Cys4-Cys9) | 
| Adrenomedullin (1-50), rat | YRQSMNQGSRSTGCRFGTCTMQKLAHQIYQFTDKDKDGMAPRNKISPQGY-NH2 (Disulfide bridge: Cys14-Cys19) | 
| Adrenomedullin (16-31), human | CRFGTCTVQKLAHQIY-NH2 | 
| Adrenomedullin (22-52), human | TVQKLAHQIYQFTDKDKDNVAPRSKISPQGY-NH2 | 
| Adrenomedullin (AM) (13-52), human | SFGCRFGTCTVQKLAHQIYQFTDKDKDNVAPRSKISPQGY-NH2 (Disulfide bridge: Cys16-Cys21) | 
| Adrenomedullin (AM) (1-52), human TFA | YRQSMNNFQGLRSFGCRFGTCTVQKLAHQIYQFTDKDKDNVAPRSKISPQGY-NH2 (Disulfide bridge: Cys16-Cys21) | 
| AGA-(C8R) HNG17, Humanin derivative | PAGASRLLLLTGEIDLP | 
| a-Helical Corticotropin Releasing Factor (12-41) | FHLLREMLEMAKAEQEAEQAALNRLLLEEA-NH2 | 
| Alexamorelin Met 1 | {d-Mrp}-Ala-Trp-{d-Phe} | 
| Alisporivir intermediate-1 | DAVVLADALLV-{Aaa}-{Abu} | 
| Allatostatin II | GDGRLYAFGL-NH2 | 
| Allatostatin III | GGSLYSFGL-NH2 | 
| Allatostatin IV | DRLYSFGL-NH2 | 
| Allatostatins/Allatostatin I | APSGAQRLYGFGL-NH2 | 
| Allergen Gal d 4 (46-61), chicken | NTDGSTDYGILQINSR | 
| Alpha 1(I) Collagen (614-639), human | SAGFDFSFLPQPPQEKAHDGGRYYRA | 
| ALX 40-4C Trifluoroacetate | Ac-{d-Arg}-{d-Arg}-{d-Arg}-{d-Arg}-{d-Arg}-{d-Arg}-{d-Arg}-{d-Arg}-{d-Arg}-NH2 | 
| AMARA peptide | AMARAASAAALARRR | 
| Amylin (8-37), rat | ATQRLANFLVRSSNNLGPVLPPTNVGSNTY-NH2 | 
| Amylin (IAPP), feline | KCNTATCATQRLANFLIRSSNNLGAILSPTNVGSNTY-NH2 (Disulfide bridge: Cys2-Cys7) | 
| Amylin, amide, human | KCNTATCATQRLANFLVHSSNNFGAILSSTNVGSNTY-NH2 (Disulfide bridge: Cys2-Cys7) | 
| Amylin, amide, rat | KCNTATCATQRLANFLVRSSNNLGPVLPPTNVGSNTY-NH2 (Disulfide bridge: Cys2-Cys7) | 
| Amyloid β-peptide (1-40) rat | DAEFGHDSGFEVRHQKLVFFAEDVGSNKGAIIGLMVGGVV | 
| Angiogenin (108-122) TFA | ENGLPVHLDQSIFRR | 
| Angiopep-2 | NH2-TFFYGGSRGKRNNFKTEEY-COOH | 
| Angiotensin Converting Enzyme Inhibitor | Glp-WPRPQIPP | 
| Angiotensin I Converting Enzyme Inhibitor | RPGFSPFR | 
| Angiotensin I, human | DRVYIHPFHL | 
| Angiotensin I/II 1-5 | DRVYI | 
| Angiotensin I/II 1-6 | DRVYIH | 
| Angiotensin II (1-4), human | DRVY | 
| Angiotensin II (3-8), human | VYIHPF | 
| Angiotensin II (5-8), human | IHPF | 
| Angiotensin II 5-valine | DRVYVHPF | 
| Angiotensin II Antipeptide | EGVYVHPV | 
| Angiotensin II, human | DRVYIHPF | 
| Angiotensin III, human | RVYIHPF | 
| Angiotensinogen (1-13), human | DRVYIHPFHLVIH | 
| Angiotensinogen (1-14), human | DRVYIHPFHLVIHN | 
| Angiotensinogen (1-14), porcine | DRVYIHPFHLLVYS | 
| Antennapedia Peptide | RQIKIWFQNRRMKWKK | 
| Anti-Inflammatory Peptide 1 | MQMKKVLDS | 
| Antioxidant peptide A | PHCKRM | 
| Apamin | CNCKAPETALCARRCQQH-NH2 (Disulfide bridge: Cys1-Cys11;Cys3-Cys15) | 
| Apelin-13, human, bovine | QRPRLSHKGPMPF | 
| Apraglutide | HGDGSFSDEX FTILDLLAAR DFINWLIQTK ITD-NH2 | 
| ARA290 | {Glp}-EQLERALNSS | 
| Arg-Gly-Asp-Cys | RGDC | 
| Arg-Gly-Asp-Ser (TFA) | RGDS | 
| Arg-Gly-Glu-Ser | Arg-Gly-Glu-Ser | 
| Argipressin | CYFQNCPRG-NH2 (Disulfide bridge: Cys1-Cys6) | 
| Argireline | Ac-EEMQRR-NH2 | 
| Asp-Asp-Asp-Asp-Asp | DDDDD | 
| Astressin | {d-Phe}-HLLREVLE-NLE-ARAEQLAQEAHKNRKL-NLE-EII-NH2 | 
| ATI-2341 | 1-Oxohexadecyl-MGYQKKLRSMTDKYRL | 
| Atrial Natriuretic Peptide (ANP) (1-28), human, porcine Acetate | SLRRSSCFGGRMDRIGAQSGLGCNSFRY (Disulfide bridge: Cys7-Cys23) | 
| Atrial Natriuretic Peptide (ANP) (1-28), rat | SLRRSSCFGGRIDRIGAQSGLGCNSFRY (Disulfide bridge: Cys7-Cys23) | 
| Autocamtide 2 | KKALRRQETVDAL | 
| Autocamtide 2, amide | KKALRRQETVDAL-NH2 | 
| Axltide | KKSRGDYMTMQIG | 
| AZP-531 | Cyclo(RVQSPEHQ) | 
| Bacterial Sortase Substrate III, Abz/DNP | Abz-LPETG-K(Dnp)-NH2 | 
| Bak BH3 | GQVGRQLAIIGDDINR | 
| BAM-22P | YGGFMRRVGRPEWWMDYQKRYG | 
| BCMA72-80 | YLMFLLRKI | 
| BDC2.5 mimotope 1040-31 | YVRPLWVRME | 
| Bim BH3, Peptide IV | DMRPEIWIAQELRRIGDEFNAYYARR | 
| Biotinyl-Angiotensin I | Biotin-DRVYIHPFHL | 
| BMf-BH3 | LQHRAEVQIARKLQCIADQFHRLHT | 
| BNP-45 (rat) | SQDSAFRIQERLRNSKMAHSSSCFGQKIDRIGAVSRLGCDGLRLF(Disulfide bridge: Cys23-Cys39) | 
| Boc-Gly-Gly-Phe-Gly-OH TFA | Boc-Gly-Gly-Phe-Gly-OH TFA | 
| Boc-Ile-Glu-Gly-Arg-AMC | Boc-Ile-Glu-Gly-Arg-AMC | 
| Bombesin | {Glp}-QRLGNQWAVGHLM-NH2 | 
| Bombinin-Like Peptide BLP-1 | GIGASILSAGKSALKGLAKGLAEHFAN-NH2 | 
| Bone Gla Protein (45-49) | FYGPV | 
| BQ-3020 TFA | N-Acetyl-LMDKEAVYFAHLDIIW | 
| Bradykinin | RPPGFSPFR | 
| Bradykinin (1-3) | RPP | 
| Bradykinin (1-5) | RPPGF | 
| Bradykinin (1-6) | RPPGFS | 
| Bradykinin (1-7) | RPPGFSP | 
| Brain Derived Acidic Fibroblast Growth Factor (102-111) | HAEKHWFVGL | 
| Brain Derived Acidic Fibroblast Growth Factor (1-11) | FNLPLGNYKKP | 
| Brain Derived Basic Fibroblast Growth Factor (1-24) | PALPEDGGSGAFPPGHFKDPKRLY | 
| Brain Natriuretic Peptide (BNP) (1-32), rat | NSKMAHSSSCFGQKIDRIGAVSRLGCDGLRLF (Disulfide bridge: Cys10-Cys26) | 
| Buserelin Acetate | {pGlu}-HWSY-{d-S(tBu)}-LRP-NHEt | 
| c(RGDfC) | c(RGDfC) | 
| c(RGDfK) | c(RGDfK) | 
| c(RGDKC) | c(RGDKC) | 
| c(RGDyC) | c(RGDyC) | 
| C3a 70-77 | ASHLGLAR | 
| Caerulein, desulfated | Glp-QDYTGWMDF-NH2 | 
| Calcineurin substrate (TFA) | DLDVPIPGRFDRRVSVAAE | 
| Calcitonin Gene Related Peptide (CGRP) (83-119), rat | SCNTATCVTHRLAGLLSRSGGVVKDNFVPTNVGSEAF-NH2 (Disulfide bridge: Cys2-Cys7) | 
| Calcitonin Gene Related Peptide (CGRP) II, rat | SCNTATCVTHRLAGLLSRSGGVVKDNFVPTNVGSKAF-NH2 (Disulfide bridge: Cys2-Cys7) | 
| Calcitonin salmon | CSNLSTCVLGKLSQELHKLQTYPRTNTGSGTP-NH2 (Disulfide bridge: Cys1-Cys7) | 
| Calcitonin, eel TFA | CSNLSTCVLGKLSQELHKLQTYPRTDVGAGTP-NH2 (Disulfide bridge: Cys1-Cys7) | 
| Calcitonin, human | CGNLSTCMLGTYTQDFNKFHTFPQTAIGVGAP-NH2 (C1&C7 bridge) | 
| Calcitonin, rat | CGNLSTCMLGTYTQDLNKFHTFPQTSIGVGAP-NH2 (C1&C7 bridge) | 
| Calmodulin Binding Peptide 1 | GVMPREETDSKTASPWKSARLMVHTVATFNSIKELNERWRSLQQLA | 
| Calmodulin-Dependent Protein Kinase II (290-309) | LKKFNARRKLKGAILTTMLA | 
| Calmodulin-Dependent Protein Kinase II 281-309 | MHRQETVDCLKKFNARRKLKGAILTTMLA | 
| cAMP Dependent PK Inhibitor (5-22), amide | TTYADFIASGRTGRRNAI-NH2 | 
| Carcinoembryonic Antigen CEA | YLSGANLNL | 
| Cardiotoxin Analog (CTX) IV (6-12) (TFA) | LIPPFWK-NH2 | 
| CART (55-76), rat | IPIYEKKYGQVPMCDAGEQCAV(Cys14&Cys20 bridge) | 
| Casein Kinase II Substrate | RRREEETEEE | 
| Casein Kinase Substrates 3 | RRKDLHDDEEDEAMSITA | 
| CD36 Peptide P (139-155) | CNLAVAAASHIYQNQFVQ | 
| CD36 Peptide P (93-110) | YRVRFLAKENVTQDAEDNC | 
| CDK2 | HHASPRK | 
| Cecropin A | KWKLFKKIEKVGQNIRDGIIKAGPAVAVVGQATQIAK-NH2 | 
| Cecropin A-melittin hybrid peptide [CA(1-7)M(2-9)NH2] | KWKLFKKIGAVLKVL-NH2 | 
| Cecropin B | KWKVFKKIEKMGRNIRNGIVKAGPAIAVLGEAKAL-NH2 | 
| Cecropin P1, porcine | SWLSKTAKKLENSAKKRISEGIAIAIQGGPR | 
| CEF1, Influenza Matrix Protein M1 58-66 | GILGFVFTL | 
| CEF14, EBV Rta Protein 28-37 | DYCNVLNKEF | 
| CEF19, Epstein-Barr Virus latent NA-3A 458-466 | YPLHEQHGM | 
| CEF27, Epstein-Barr Virus BRLF-1 lytic 148-156 | RVRAYTYSK | 
| CEF3 | SIIPSGPLK | 
| CEF4 | RVLSFIKGTK | 
| CEF6 | LPFDKTTVM | 
| CEF7, Influenza Virus NP 380-388 | ELRSRYWAI | 
| CEF8, Influenza Virus NP 383-391 | SRYWAIRTR | 
| Ceratotoxin A | SIGSALKKALPVAKKIGKIALPIAKAALP | 
| Ceratotoxin B | SIGSAFKKALPVAKKIGKAALPIAKAALP | 
| Cerebellin | SGSAKVAFSAIRSTNH | 
| CH 5450 | Z-Ile-Glu-Pro-Phe-Ome | 
| Chemerin-9 149-157 | YFPGQFAFS | 
| Chlorotoxin(linear) | MCMPCFTTDHQMARKCDDCCGGKGRGKCYGPQCLCR-NH2 | 
| Cholecystokinin, CCK Octapeptide (26-33), Non-Sulfated form | DYMGWMDF-NH2 | 
| Cholecystokinin, CCK Tetrapeptide (30-33) | WMDF-NH2 | 
| Chromostatin, bovine | SDEDSDGDRPQASPGLGPGP | 
| CLIP 86-100 | PVSKMRMATPLLMQA | 
| c-Myc Peptide Trifluoroacetate | EQKLISEEDL | 
| Colivelin | SALLRSIPAPAGASRLLLLTGEIDLP | 
| Collagen Binding Fragment | CQDSETRTFY | 
| Competence-Stimulating Peptide-12261 | EIRQTHNIFFNFFKRR | 
| Compstatin | ICVVQDWGHHRCT-NH2 (Disulfide bridge: Cys2-Cys12) | 
| Conopressin S | CIIRNCPRG-NH2 (Disulfide bridge: Cys1-Cys6) | 
| Corazonin | Glp-TFQYSRGWTN-NH2 | 
| Corticotropin-releasing factor human | SEEPPISLDLTFHLLREVLEMARAEQLAQQAHSNRKLMEII-NH2 | 
| Cortistatin 14, human, rat | PCKNFFWKTFSSCK (Disulfide bridge: Cys2-Cys13) | 
| Cortistatin 29 (1-13) | Glp-ERPPLQQPPHRD | 
| Cortistatin-14 | PCKNFFWKTFSSCK-NH2 (Disulfide bridge: Cys2-Cys13) | 
| C-Peptide, dog | EVEDLQVRDVELAGAPGEGGLQPLALEGALQ | 
| C-Reactive Protein (CRP) 174-185 | IYLGGPFSPNVL | 
| C-Reactive Protein (CRP) 201-206 | KPQLWP | 
| C-Reactive Protein (CRP) 77-82 | VGGSEI | 
| CREBtide | KRREILSRRPSYR | 
| CRF, bovine | SQEPPISLDLTFHLLREVLEMTKADQLAQQAHNNRKLLDIA-NH2 | 
| Crustacean Cardioactive Peptide CCAP | PFCNAFTGC | 
| C-telopeptide | EKAHDGGR | 
| CTTHWGFTLC, CYCLIC | CTTHWGFTLC (Disulfide Bridge: Cys1-Cys10) | 
| C-Type Natriuretic Peptide (1-53), human | DLRVDTKSRAAWARLLQEHPNARKYKGANKKGLSKGCFGLKLDRIGSMSGLGC | 
| C-Type Natriuretic Peptide (CNP) (1-22), human | GLSKGCFGLKLDRIGSMSGLGC (Disulfide bridge: Cys6-Cys22) | 
| Cyclic MKEY | CKEYFYTSSKSSNLAVVFVTRC | 
| Cyclic somatostatin | HAGCKNFFWKTFTSC-OH (Disulfide bridge: Cys3-Cys14) | 
| Cyclo(Phe-Pro) | Cyclo(Phe-Pro) | 
| Cyclo(RADfK) | Cyclo(Ala-Asp-Phe-Lys-Arg) | 
| Cyclo(RGDyK) | Cyclo(RGDyK) | 
| Cyclosporin A-Derivative 1 | LVLADALLV-{Aaa}-{Abu}-{Sar} | 
| Cyclosporin A-Derivative 2 | VLADALLV-{Aaa}-{Abu}-{Sar} | 
| CYN 154806 | Ac-FCYWKTCY-NH2 (Disulfide bridge: Cys2-Cys7) | 
| CysHHC10 TFA | CKRWWKWIRW-NH2 | 
| Cys-TAT(47-57) | CYGRKKRRQRRR-NH2 | 
| DAMGO | Y-{d-Ala}-G-{Me-Phe}-G-ol | 
| DAPTA | ASTTTNYT-NH2 | 
| Delta-Sleep Inducing Peptide | WAGGDASGE | 
| Dermaseptin | ALWKTMLKKLGTMALHAGKAALGAAADTISQGTQ | 
| Dermorphin Analog | Y-{d-Arg}-F-{SAR}-YPS-NH2 | 
| Diazepam-Binding Inhibitor Fragment, human | QATVGDINTERPGMLDFTGK | 
| Difopein TFA | SADGAPHCVPRDLSWLDLEANMCLPGAAGLDSADGAPHCVPRDLSWLDLEANMCLPGAAGLE | 
| D-Lys(Z)-Pro-Arg-pNA | {d-Lys(Z)}-PR-pNA | 
| D-Lys(Z)-Pro-Arg-pNA diacetate | {d-Lys(Z)}-P-R-pNA | 
| Dynorphin (2-17), amide, porcine | GGFLRRIRPKLKWDNQ-NH2 | 
| Dynorphin A (1-13), amide, porcine | YGGFLRRIRPKLK-NH2 | 
| Dynorphin A (1-13), porcine | YGGFLRRIRPKLK | 
| Dynorphin A (1-17) | YGGFLRRIRPKLKWDNQ | 
| Dynorphin A (2-17), porcine | GGFLRRIRPKLKWDNQ | 
| Dynorphin A 1-10 | YGGFLRRIRP | 
| Dynorphin A amide, porcine | YGGFLRRIRPKLKWDNQ-NH2 | 
| Dynorphin B (1-13) | YGGFLRRQFKVVT | 
| Dynorphin B (1-9) | YGGFLRRQF | 
| EGF Receptor Substrate 2 Phospho-Tyr5 | HDADE-{pTyr}-LIPQQG-OH | 
| EGFRvIII peptide PEPvIII | LEEKKGNYVVTDHC | 
| Egg Laying Hormone, aplysia | ISINQDLKAITDMLLTEQIRERQRYLADLRQRLLEK-NH2 | 
| Elamipretide | {d-Arg}-Dmt-KF-NH2 | 
| Eledoisin | {Glp}-PSKDAFIGLM-NH2 | 
| Eledoisin Related Peptide | KFIGLM-NH2 | 
| Endothelin-2, human | CSCSSWLDKECVYFCHLDIIW (Disulfide bridge: Cys1-Cys15, Cys3-Cys11) | 
| Endothelin-3, human, mouse, rabbit, rat | CTCFTYKDKECVYYCHLDIIW(Disulfide bridge: Cys1-Cys15, Cys3-Cys11) | 
| Enfuvirtide | Ac-YTSLIHSLIEESQNQQEKNEQELLELDKWASLWNWF-NH2 | 
| Enterostatin, human, mouse, rat | APGPR | 
| Epidermal Growth Factor Receptor Peptide (985-996) | DVVDADEYLIPQ | 
| Epithalon TFA | AEDG | 
| Etelcalcetide hydrochloride | C'-Ac-d-C-d-A-d-R-d-R-d-R-d-A-d-R-NH2 (Disulfide bridge: Cys1'-Cys1) | 
| EXENDIN (9-39) | DLSKQMEEEAVRLFIEWLKNGGPSSGAPPPS-NH2 | 
| Exendin derivative 1 | HAEGTFTSDVSKQMEEEAVRLFIEWLKNGGPSSGAPPPSLMNPQRSTVWY | 
| Exendin-3 | HSDGTFTSDLSKQMEEEAVRLFIEWLKNGGPSSGAPPPS-NH2 | 
| Exendin-3/4 (59-86) | KQMEEEAVRLFIEWLKNGGPSSGAPPPS | 
| Exendin-3/4 (64-86) | EAVRLFIEWLKNGGPSSGAPPPS | 
| Exendin-4 | HGEGTFTSDLSKQMEEEAVRLFIEWLKNGGPSSGAPPPS-NH2 | 
| Fam-Bradykinin | 5FAM-RPPGFSPFR | 
| Fertirelin | {Glp}-HWSYGLRP | 
| FFAGLDD | FFAGLDD | 
| FHV Coat-(35–49) | RRRRNRTRRNRRRVR | 
| Fibrinogen Binding Inhibitor Peptide | HHLGGAKQAGDV | 
| Fibrinogen-Binding Peptide | EHIPA | 
| Fibrinopeptide A, human | ADSGEGDFLAEGGGVR | 
| Fibrinopeptide B, human | {Glp}-GVNDNEEGFFSAR | 
| Fibronectin Active Fragment Control | GRGES | 
| Fibronectin Adhesion-promoting Peptide | WQPPRARI | 
| Fibronectin CS1 Peptide | EILDVPST | 
| Flag Peptide | DYKDDDDK | 
| Flagelin 22(TFA) | QRLSTGSRINSAKDDAAGLQIA | 
| FliC, Serotype a (427-441), S.paratyphi A | VQNRFNSAITNLGNT | 
| Fmoc-N-Me-Ala-OH | Fmoc-N-Me-Ala-OH | 
| Fmoc-N-Me-Leu-OH | Fmoc-N-Me-Leu-OH | 
| Fmoc-N-Me-Phe-OH | Fmoc-N-Me-Phe-OH | 
| Fmoc-Val-Cit-PAB-PNP | Fmoc-V-Cit-PAB-PNP | 
| FMRF | FMRF | 
| FMRF-amide | FMRF-NH2 | 
| Foxy-5 | MDGCEL | 
| G280-9 | YLEPGPVTA | 
| Galanin (1-16), mouse, porcine, rat TFA | GWTLNSAGYLLGPHAI | 
| Galanin (1-19), human | GWTLNSAGYLLGPHAVGNH | 
| Galanin, human | GWTLNSAGYLLGPHAVGNHRSFSDKNGLTS | 
| Galanin, rat | GWTLNSAGYLLGPHAIDNHRSFSDKHGLT-NH2 | 
| Galantide | GWTLNSAGYLLGPQQFFGLM-NH2 | 
| Gap26 | VCYDKSFPISHVR | 
| GAP27 | SRPTEKTIFII | 
| Gastrin 1, human | Pyr-GPWLEEEEEAYGWMDF-CONH2 | 
| Gastrin I (1-14), human | Glp-GPWLEEEEEAYGW | 
| Gastrin-Releasing Peptide, human | VPLPAGGGTVLTKMYPRGNHWAVGHLM-NH2 | 
| GHRF (1-29), amide, human | YADAIFTNSYRKVLGQLSARKLLQDIMSR-NH2 | 
| GHRF (1-29), amide, rat | HADAIFTSSYRRILGQLYARKLLHEIMNR-NH2 | 
| GIP (1-30) amide (Human) | YAEGTFISDYSIAMDKIHQQDFVNWLLAQK-NH2 | 
| GLGPNPCRKKCYKRDFLGR | GLGPNPCRKKCYKRDFLGR | 
| GLP-1 (7-36), amide, chicken, common turkey | HAEGTYTSDITSYLEGQAAKEFIAWLVNGR-NH2 | 
| GLP-1 (7-37) (human, bovine, guinea pig, mouse, rat) | HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG | 
| GLP-1 moiety from Dulaglutide | HGEGTFTSDVSSYLEEQAAKEFIAWLVKGGG | 
| GLP-1(7-36) Acetate | HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRNH2 | 
| GLP-1(7-37) | HAEGTFTSDVSSYLEGQAAKEFIAWLVKG-R-G | 
| GLP-1/Glucagon-Like Peptide, amide, human | HDEFERHAEGTFTSDVSSYLEGQAAKEFIAWLVKGR-NH2 | 
| GLP-1/Glucagon-Like Peptide, human | HDEFERHAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG | 
| GLP-2, human | HADGSFSDEMNTILDNLAARDFINWLIQTKITD | 
| Glucagon (19-29), human | AQDFVQWLMNT | 
| Glucagon, human | HSQGTFTSDYSKYLDSRRAQDFVQWLMNT | 
| Glucagon-Like Peptide II, human | HADGSFSDEMNTILDNLAARDFINWLIQTKITDR | 
| Glucagon-Like Peptide II, rat | HADGSFSDEMNTILDNLATRDFINWLIQTKITD | 
| Gluten Exorphin B5 | YGGWL | 
| Gluten Exorphin C | YPISL | 
| Gly6 | GGGGGG | 
| Gly-Arg-Gly-Asp-Ser | GRGDS | 
| Glycoprotein 276-286 | SGVENPGGYCL | 
| Gly-Phe-Arg | GFR | 
| GnRH-I | Pyr-HWSYGLRPG-NH2 | 
| GP(33-41) | KAVYNFATC | 
| Gp100 (25-33), human | KVPRNQDWL | 
| Gp100 619-627 | RLMKQDFSV | 
| GPRP acetate | GPRP | 
| G-R-G-D-S-P | GRGDSP | 
| GRGDSPC | GRGDSPC | 
| GRGDSPK | GRGDSPK | 
| GroES mobile loop | ETKSAGGIVLTGS | 
| GsMTx4 | GCLEFWWKCNPNDDKCCRPKLKCSKLFKLCNFSF | 
| GTFTSDVSKQMEEEAVRLFIEWLKNGGPSSGAPPPS | GTFTSDVSKQMEEEAVRLFIEWLKNGGPSSGAPPPS | 
| GTP-Binding Protein Fragment, Gs alpha | CKQLQKDKQVYRATHR | 
| HA Peptide | YPYDVPDYA | 
| HAE | His-Ala-Glu | 
| HAEGT | HAEGT | 
| HAEGTFTSD | HAEGTFTSD | 
| HAEGTFTSDVS | HAEGTFTSDVS | 
| HAEGTFTSDVSSYLE | HAEGTFTSDVSSYLE | 
| H-Ala-Ala-Tyr-OH | H-Ala-Ala-Tyr-OH | 
| Handle region peptide, rat | RILLKKMPSV | 
| HCGRP-(8-37) | VTHRLAGLLSRSGGVVKNNFVPTNVGSKAF | 
| Hemoglobin (Hb) (64-76) | GKKVITAFNEGLK | 
| Hemokinin 1 (mouse) | RSRTRQFYGLM-NH2 | 
| Hemorphin-7 | YPWTQRF | 
| Hepatitis B Virus Core 128-140 | TPPAYRPPNAPIL | 
| HER2/neu (654-662) GP2 | IISAVVGIL | 
| HEX3 | KYSPSNVKI | 
| Hexa His | HHHHHH | 
| H-Gly-Gly-Pro-OH | H-Gly-Gly-Pro-OH | 
| H-Gly-Pro-OH | H-Gly-Pro-OH | 
| HIF-1 alpha 556-574 | DLDLEMLAPYIPMDDDFQL | 
| H-Ile-Pro-Pro-OH | Ile-Pro-Pro | 
| His-[D-2-ME-Trp]-Ala | His-{d-2-Me-Trp}-Ala | 
| His-Pro | His-Pro | 
| His-Pro hydrochloride | His-Pro hydrochloride | 
| Histatin 5 | DSHAKRHHGYKRKFHEKHHSHRGY | 
| Histone H1-derived Peptide | GGGPATPKKAKKL | 
| Histone H4 (2-21) | SGRGKGGKGLGKGGAKRHRK | 
| HIV (gp120) Fragment (318-327) | RGPGRAFVTI | 
| HIV (gp41) Fragment | AVGIGA | 
| HIV gag peptide 197-205 | AMQMLKETI | 
| HIV p17 Gag 77-85 | SLYNTVATL | 
| HIV-1 env Protein gp41 (1-23) amide (isolates BRU/JRCSF) | AVGIGALFLGFLGAAGSTMGARS-NH2 | 
| HIV-1 gag Protein p24 (194-210) | ANPDCKTILKALGPAAT | 
| HIV-1 Rev 34-50 | TRQARRNRRRRWRERQR | 
| HIV-1 TAT 48-60 | GRKKRRQRRRPPQ | 
| HIV-1 tat Protein (1-9) | MDPVDPNIE | 
| HIV-1 tat Protein (49-57) | RKKRRQRRR | 
| HIV-1 TAT Protein Peptide | NH2-YGRKKRRQRRR-COOH | 
| HPV16 E7 86-93 | TLGIVCPI | 
| HPV16-E711-20 epitope | YMLDLQPETT | 
| Hsp70-derived octapeptide | GPTIEEVD | 
| HSV-gB2 498-505 | SSIEFARL | 
| Human CMV pp65 (495-503) | NLVPMVATV | 
| Human growth hormone-releasing factor | YADAIFTNSYRKVLGQLSARKLLQDIMSRQQGESNQERGARARL-NH2 | 
| Human Papillomavirus (HPV) E7 protein 49-57 | RAHYNIVTF | 
| H-Val-Pro-Pro-OH | H-Val-Pro-Pro-OH | 
| Hypercalcemia Malignancy Factor (1-34), amide, human | AVSEHQLLHDKGKSIQDLRRRFFLHHLIAEIHTA-NH2 | 
| Hypercalcemia Malignancy Factor (1-34), human | AVSEHQLLHDKGKSIQDLRRRFFLHHLIAEIHTA | 
| IFN-α Receptor Recognition Peptide 1 | CLKDRHD | 
| IGF-I (24-41) TFA | YFNKPTGYGSSSRRAPQT | 
| IGF-I (30-41) TFA | GYGSSSRRAPQT | 
| IKKγ NBD Inhibitory Peptide | DRQIKIWFQNRRMKWKKTALDWSWLQTE | 
| Ile-Thr-Asp-Gln-Val-Pro-Phe-Ser-Val | ITDQVPFSV | 
| Indolicidin | ILPWKWPWWPWRR-NH2 | 
| Influenza A NP(366-374) Strain A/PR/8/35 | ASNENMETM | 
| Influenza HA 126-138 | HNTNGVTAASSHE | 
| Influenza HA 307-319 | PKYVKQNTLKLAT | 
| Influenza HA 518-526 | IYSTVASSL | 
| Influenza NP 147-155 | TYQRTRALV | 
| Insulin alpha-chain 1-13 | KRGIVEQCCTSICSL | 
| Insulin B (9 - 23) | SHLVEALYLVCGERG | 
| Interleukin (IL)-6 Receptor | TSLPVQDSSSVP | 
| Interphotoreceptor Retinoid Binding Protein Fragment IRBP | SGIPYIISYLHPGNTILHVD | 
| Interphotoreceptor retinoid-binding protein(668-687) | LAQGAYRTAVDLESLASQLT | 
| IRBP (1-20), human | GPTHLFQPSLVLDMAKVLLD | 
| iRGD | c(CRGDKGPDC) | 
| IRL-1620 TFA | Suc-DEEAVYFAHLDIIW | 
| IRL-1720 | Ac-DKEAVYFAHLDIIW | 
| Iα52 | ASFEAQGALANIAVDKA | 
| JAG-1, scrambled | RCGPDCFDNYGRYKYCF | 
| Jagged-1 188-204 | CDDYYYGFGCNKFCRPR | 
| Kassinin | DVPKSDQFVGLM-NH2 | 
| Katacalcin | DMSSDLERDHRPHVSMPQNAN | 
| Kemptide | LRRASLG | 
| Kemptide Phospho-Ser5 | LRRA-{pSer}-LG | 
| Kinetensin | IARRHPYFL | 
| Kisspeptin-10, human (TFA) | YNWNSFGLRF-NH2 | 
| Kisspeptin-10, rat | YNWNSFGLRY-NH2 | 
| KKI-5 | Ac-PFRSVQ-NH2 | 
| Kv3, Channel Containing Protein 567-585 | CKESPVIAKYMPTEAVRVT | 
| L-Leucyl-L-alanine | L-Leucyl-L-alanine | 
| Lactoferricin, bovine, (BLFC) | RRWQWRMKKLG | 
| Lactoferrin (17-41) TFA | FKCRRWQWRMKKLGAPSITCVRRAF (Disulfide bridge: Cys3-Cys20) | 
| LAH4 | KKALLALALHHLAHLALHLALALKKA | 
| Laminin (925-933) | CDPGYIGSR | 
| Laminin (929-933) | YIGSR | 
| Laminin A Chain (2091-2108) | CSRARKQAASIKVAVSADR | 
| Laminin Penta Peptide, amide | YIGSR-NH2 | 
| LCMV gp33-41 | KAVYNFATM | 
| Lecirelin | {Glp}-HWSYVLRP | 
| LEP(116-130)(mouse) | SCSLPQTSGLQKPES-NH2 | 
| Leptin (116-130), mouse | SCSLPQTSGLQKPES | 
| Leptin (22-56), human | VPIQKVQDDTKTLIKTIVTRINDISHTQSVSSKQK | 
| Leptin (93-105), human | NVIQISNDLENLR | 
| Leucokinin I | DPAFNSWG | 
| Leucokinin VIII | GASFYSWG-NH2 | 
| LGnRH-III, lamprey | {pGLP}-HWSHDWKPG-NH2 | 
| LH-RH, Free Acid | Glp-HWSYGLRPG | 
| LH-RH, human, Gonadoreline | Glp-HWSYGLRPG-NH2 | 
| LH-RH, lamprey | Glp-HYSLEWKPG-NH2 | 
| LH-RH, salmon | Glp-HWSYGWLPG-NH2 | 
| Lixisenatide | HGEGTFTSDLSKQMEEEAVRLFIEWLKNGGPSSGAPPSKKKKKK-NH2 | 
| L-JNKI-1 | DQSRPVQPFLNLTTPRKPRPPRRRQRRKKRG-NH2 | 
| LL-37 | LLGDFFRKSKEKIGKEFKRIVQRIKDFLRNLVPRTES | 
| LL-37 scrambled peptide | GLKLRFEFSKIKGEFLKTPEVRFRDIKLKDNRISVQR | 
| LL-37, acetylated,amidated | Ac-LLGDFFRKSKEKIGKEFKRIVQRIKDFLRNLVPRTES-NH2 | 
| LSKL, Inhibitor of Thrombospondin TSP-1 | LSKL | 
| LTX-315 | KKWWKKW-Dip-K-NH2 | 
| Luteinizing Hormone Releasing Hormone (LH-RH), human | {Glp}-HWSYGLRPG-NH2 | 
| Lysozyme | RVVRDPQGIRAWVAWRNR | 
| M-2420 | Methoxycoumarin-Ser-Glu-Val-Asn-Leu-Asp-Ala-Glu-Phe-Lys-dinitrophenyl | 
| M35 | GWTLNSAGYLLGPPPGFSPFR-NH2 | 
| M40 | GWTLNSAGYLLGPPPALALA-NH2 | 
| Magainin 2 | GIGKFLHSAKKFGKAFVGEIMNS | 
| Magainin I | GIGKFLHSAGKFGKAFVGEIMKS | 
| Magainin Spacer Peptide | DAEAVGPEAFADQDLDEREVR | 
| Mage-1 Antigen (161-169), human | EADPTGHSY | 
| MAGE-3 Antigen (167-176), human | MEVDPIGHLY | 
| MAGE-3 Antigen (271-279), human | FLWGPRALV | 
| MAGE-A3 195-203 | IMPKAGLLI | 
| Malantide | RTKRSGSVYEPLKI | 
| MARCKS Peptide(151-175), Phosphorylated | KKKKKRF-{pSer}-FKK-{pSer}-FKLSGF-{pSer}-FKKNKK | 
| MARK Substrate | NVKSKIGSTENLK | 
| MART-1 (26-35) human | EAAGIGILTV | 
| Mas7 | INLKALAALAKALL-NH2 | 
| Mast cell degranulating peptide (28-49) | IKCNCKRHVIKPHICRKICGKN-NH2 | 
| Mast Cell Degranulating Peptide HR-1 | INLKAIAALVKKVL-NH2 | 
| Mast Cell Degranulating Peptide HR-2 | FLPLILGKLVKGLL-NH2 | 
| Mastoparan | INLKALAALAKKIL-NH2 | 
| Mastoparan X | INWKGIAAMAKKLL-NH2 | 
| MCA-SEVNLDAEFR-K(Dnp)-RR, amide | MCA-SEVNLDAEFR-K(Dnp)-RR-NH2 | 
| Melanin Concentrating Hormone, salmon | DTMRCMVGRVYRPCWEV (Disulfide bridge: Cys5-Cys14) | 
| Melanocyte-Stimulating Hormone-Release Inhibiting Factor | PLG-NH2 | 
| Melittin | GIGAVLKVLTTGLPALISWIKRKRQQ-NH2 | 
| Men 10376 | DY-DTrp-V-DTrp-DTrp-K-NH2 | 
| Men 10376 TFA | Asp-Tyr-{d-Trp}-Val-{d-Trp}-{d-Trp}-Lys-NH2 | 
| Met-Enkephalin | YGGFM | 
| MG-132 | RPKPQQFFGLM-NH2 | 
| Microtubule-associated protein tau (26-44) | QGGYTMHQDQEGDTDAGLK | 
| Mini Gastrin I, human | LEEEEEAYGWMDF-NH2 | 
| MOG 35-55 | MEVGWYRSPFSRVVHLYRNGK | 
| Moth Cytochrome C (MCC) 88-103 | ANERADLIAYLKQATK | 
| Motilin, canine | FVPIFTHSELQKIREKERNKGQ | 
| Motilin, human, porcine | FVPIFTYGELQRMQEKERNKGQ | 
| MPG, HIV related | GALFLGFLGAAGSTMGAWSQPKSKRKV | 
| mTRP-2 180-188 | SVYDFFVWL | 
| MUC5AC motif peptide | GTTPSPVPTTSTTSAP | 
| Murepavadin TFA | Cyclo(AS-{d-Pro}-PTWI-{Dab}-{Orn}-{d-Dab}-{Dab}-W-{Dab}-{Dab}) | 
| Myelin Basic Protein (68-84), guinea pig | YGSLPQKSQRSQDEN | 
| Myelin Basic Protein (87-99) (human, bovine, rat) | VHFFKNIVTPRTP | 
| Myelopeptide-2 (MP-2) | LVVYPW | 
| Myomodulin | PMSMLRL-NH2 | 
| Myosin Kinase Inhibiting Peptide | KKRAARATS-NH2 | 
| N-Acetyl, ACTH (1-17), human | Ac-SYSMEHFRWGKPVGKKR | 
| N-Acetyl-Ser-Asp-Lys-Pro | Ac-SDKP | 
| N-Acetyl-α-Endorphin | Ac-YGGFMTSEKSQTPLVT | 
| N-Boc-Phe-Leu-Phe-Leu-Phe | N-Boc-Phe-Leu-Phe-Leu-Phe | 
| N-CBZ-Phe-Arg-AMC | CBZ-FR-AMC | 
| Nesiritide | SPKMVQGSGCFGRKMDRISSSSGLGCKVLRRH (Disulfide bridge: Cys10-Cys26) | 
| Neurokinin A / Substance K | HKTDSFVGLM-NH2 | 
| Neurokinin A(4-10) | DSFVGLM-NH2 | 
| Neurokinin B | DMHDFFVGLM-NH2 | 
| Neuromedin (U25), human | FRVDEEFQSPFASQSRGYFLFRPRN-NH2 | 
| Neuromedin B | GNLWATGHFM-NH2 | 
| Neuromedin C | GNHWAVGHLM-NH2 | 
| Neuromedin N | KIPYIL | 
| Neuromedin U, rat | YKVNEYQGPVAPSGGFFLFRPRN-NH2 | 
| Neuronostatin-13 human | LRQFLQKSLAAAA-NH2 | 
| Neuropeptide AF (93-110), Human | AGEGLNSQFWSLAAPQRF-NH2 | 
| Neuropeptide EI, rat | EIGDEENSAKFPI-NH2 | 
| Neuropeptide FF | FLFQPQRF-NH2 | 
| Neuropeptide K, porcine | DADSSIEKQVALLKALYGHGQISHKRHKTDSFVGLM-NH2 | 
| Neuropeptide W-23(human) | WYKHVASPRYHTVGRAAGLMGL | 
| Neuropeptide Y (13-36), human | PAEDMARYYSALRHYINLITRQRY-NH2 | 
| Neuropeptide Y (22-36) | SALRHYINLITRQRY-NH2 | 
| Neuropeptide Y(29-64) | YPSKPDNPGEDAPAEDMARYYSALRHYINLITRQRY | 
| Neuropeptide Y, human | YPSKPDNPGEDAPAEDMARYYSALRHYINLITRQRY-NH2 | 
| Neurotensin | Pyr-LYENKPRRPYIL | 
| Neurotensin (8-13) | RRPYIL | 
| NFAT Inhibitor | MAGPHPVIVITGPHEE | 
| N-Formyl-Met-Ala-Ser | Formyl-MAS | 
| N-Formyl-Met-Leu-Phe | Formyl-MLF | 
| N-Formyl-Met-Leu-Phe-Lys | Formyl-MLFK | 
| N-Formyl-Nle-Leu-Phe-Nle-Tyr-Lys | N-Formyl-{NLE}-LF-{NLE}-YK | 
| NGR peptide Trifluoroacetate | CNGRCG | 
| NH2-KLGADTDGEQDQHMTYGGQ-COOH | KLGADTDGEQDQHMTYGGQ | 
| NLS PKKKRKV | PKKKRKV | 
| Nociceptin (1-13), amide | FGGFTGARKSARK-NH2 | 
| Nociceptin / Orphanin FQ | FGGFTGARKSARKLANQ | 
| Nocistatin | EQKQLQ | 
| NT 13 | TPPT | 
| NTB (Naltriben) | DPhe-CY-DTrp-Orn-T-Pen-T-NH2(Cys2&Pen7 bridge) | 
| N-terminally acetylated Endomorphin-1 | Ac-LYLPLWLF-NH2 | 
| N-terminally acetylated Leu-enkephalin | Ac-LYGGLFDL-COOH | 
| Nuclear pore complex protein Nup98 315-360 | Ac-MGLFGVTQASQPGGLFGTATNTSTGTAFGTGTGLFGQTNTGFGAV | 
| Nucleoprotein 118-126 | RPQASGVYM | 
| Nucleoprotein 396-404 | FQPQNGQFI | 
| NY-BR-1 p904 A2 | SLSKILDTV | 
| Obestatin (human) | FNAPFDVGIKLSGVQYQQHSQAL-NH2 | 
| Octreotide | FCFWKTCT (Disulfide bridge: Cys2-Cys7) | 
| Orexin B, canine | RPGPPGLQGRLQRLLQASGNHAAGILTM-NH2 | 
| Orexin B, human | RSGPPGLQGRLQRLLQASGNHAAGILTM-NH2 | 
| Orexin B, rat, mouse | RPGPPGLQGRLQRLLQANGNHAAGILTM-NH2 | 
| Ornipressin | CYFQNCP-{Orn}-G-NH2 (Disulfide bridge: Cys1-Cys6) | 
| Osteocalcin (37-49), human | GFQEAYRRFYGPV | 
| Osteogenic Growth Peptide, OGP | ALKRQGRTLYGFGG | 
| OV-1, sheep | KNLRRIIRKIIHIIKKYG | 
| OVA 323-339 | ISQAVHAAHAEINEAGR | 
| OVA G4 peptide | SIIGFEKL | 
| OVA peptide (257-264) | SIINFEKL | 
| OVA sequence 323-336 | ISQAVHAAHAEINE | 
| p2Ca | LSPFPFDL | 
| P34cdc2 Kinase Substrate Peptide | ADAQHATPPKKKRKVEDPKDF | 
| p5 Ligand for Dnak and DnaJ | CLLLSAPRR | 
| p53 17-26 | ETFSDLWKLL | 
| PA (224-233), Influenza | SSLENFRAYV | 
| PACAP (1-27), human, ovine, rat | HSDGIFTDSYSRYRKQMAVKKYLAAVL-NH2 | 
| PACAP (1-38), human, ovine, rat | HSDGIFTDSYSRYRKQMAVKKYLAAVLGKRYKQRVKNK-NH2 | 
| PACAP (6-27), human, ovine, rat | FTDSYSRYRKQMAVKKYLAAVL-NH2 | 
| PACAP (6-38), human, ovine, rat | FTDSYSRYRKQMAVKKYLAAVLGKRYKQRVKNK-NH2 | 
| PACAP-38 (16-38), human, mouse, rat | QMAVKKYLAAVLGKRYKQRVKNK-NH2 | 
| PACAP-38 (31-38), human, mouse, rat | YKQRVKNK-NH2 | 
| PACAP-Related Peptide (PRP), human | DVAHGILNEAYRKVLDQLSAGKHLQSLVA | 
| PACAP-Related Peptide (PRP), rat | DVAHEILNEAYRKVLDQLSARKYLQSMVA | 
| Palmitoyl Tetrapeptide-3 | Palm-GQPR | 
| Pancreatic Polypeptide (human) | APLEPVYPGDNATPEQMAQYAADLRRYINMLTRPRY-NH2 | 
| Pancreatic Polypeptide (rat) | APLEPMYPGDYATHEQRAQYETQLRRYINTLTRPRY-NH2 | 
| Pancreatic Polypeptide, bovine | APLEPEYPGDNATPEQMAQYAAELRRYINMLTRPRY-NH2 | 
| PAR - 1 Agonist;Protease - Activated Receptor - 1 | TFLLRN | 
| PAR-4 (1-6) (human) | GYPGQV | 
| PAR-4 (1-6) (mouse) | GYPGKF | 
| PAR-4 (1-6) amide (human) | GYPGQV-NH2 | 
| PAR-4 (1-6) amide (mouse) | GYPGKF-NH2 | 
| PAR-4 Agonist Peptide, amide | AYPGKF-NH2 | 
| Parasin I (TFA) | KGRGKQGGKVRAKAKTRSS | 
| Parathyroid Hormone (1-34), bovine | AVSEIQFMHNLGKHLSSMERVEWLRKKLQDVHNF | 
| Parathyroid Hormone (1-34), rat | AVSEIQLMHNLGKHLASVERMQWLRKKLQDVHNF | 
| Pep-1 | KETWWETWWTEWSQPKKKRKV | 
| Peptide 401 | IKCNCKRHVIKPHICRKICGKN-NH2 (Disulfide bridge: Cys3-Cys15, Cys5-Cys19) | 
| Peptide C105Y | CSIPPEVKFNKPFVYLI | 
| Peptide M | DTNLASSTIIKEGIDKTV | 
| Peptide T | ASTTTNYT | 
| Peptide YY (PYY) (3-36), human | IKPEAPGEDASPEELNRYYASLRHYLNLVTRQRY-NH2 | 
| Peptide YY (PYY), human | YPIKPEAPGEDASPEELNRYYASLRHYLNLVTRQRY-NH2 | 
| PGLa | GMASKAGAIAGKIAKVALKAL-NH2 | 
| pGlu-Pro-Arg-MNA | {pGlu}-PR-MNA | 
| pGlu-Pro-Arg-MNA monoacetate | {pGlu}-Pro-Arg-MNA | 
| Phe-Met-Arg-Phe Like Peptide | {pGLU}-DPFLRF | 
| PHI, rat | HADGVFTSDYSRLLGQISAKKYLESLI-NH2 | 
| Phosphate Acceptor Peptide | RRKASGPPV | 
| Phosphorylase Kinase b-Subunit (420-436) | KRNPGSQKRFPSNCGRD | 
| P-H-P-F-H-F-F-V-Y-K | PHPFHFFVYK | 
| Phyllomedusin | Glp-NPNRFIGLM-NH2 | 
| Physalaemin | Glp-ADPNKFYGLM-NH2 | 
| Piscidin-1 (22-42) | GFIFHIIKGLFHAGKMIHGLV-NH2 | 
| PKG Substrate | RKRSRAE | 
| Platelet Factor 4 (58-70), human | PLYKKIIKKLLES | 
| PLP 139-151 | HCLGKWLGHPDKF | 
| PN: US20040072744 SEQID: 2 claimed protein | NLGEHPVCDS | 
| Prepro VIP (111-122), human | VSSNISEDPVPV | 
| Prepro VIP (81-122), human | HADGVFTSDFSKLLGQLSAKKYLESLMGKRVSSNISEDPVPV | 
| Pressinoic Acid | CYFQNC (Disulfide bridge: Cys1-Cys6) | 
| Proadrenomedullin (45-92), human | ELRMSSSYPTGLADVKAGPAQTLIRPQDMKGASRSPEDSSPDAARIRV | 
| Pro-Adrenomedullin (N-20), human | ARLDVASEFRKKWNKWALSR-NH2 | 
| Pro-Adrenomedullin (N-20), porcine | ARLDVAAEFRKKWNKWALSR-NH2 | 
| Pro-Adrenomedullin (N-20), rat | ARLDTSSQFRKKWNKWALSR-NH2 | 
| Proctolin | RYLPT | 
| Proinsulin C-Peptide (55-89), ?human | RREAEDLQVGQVELGGGPGAGSLQPLALEGSLQKR | 
| Proinsulin C-peptide human | EAEDLQVGQVELGGGPGAGSLQPLALEGSLQ | 
| Prolactin Releasing Peptide (12-31), human | TPDINPAWYASRGIRPVGRF-NH2 | 
| Prolactin Releasing Peptide (1-31), human | SRTHRHSMEIRTPDINPAWYASRGIRPVGRF-NH2 | 
| Prolylleucine | Z-Pro-{d-Leu} | 
| Protease-Activated Receptor-2 Activating Peptide | SLIGRL-NH2 | 
| Protease-Activated Receptor-2, PAR-2 Agonist, amide | SLIGKV-NH2 | 
| Protein Kinase C (19-35) Peptide | RFARKGALRQKNVHEVK | 
| Protein Kinase C (gamma) Peptide | NYPLELYERVRTGC | 
| Protein Kinase C 19-31 | RFARKGALRQKNV | 
| Protein Kinase C 19-36 | RFARKGALRQKNVHEVKN | 
| Protein Kinase C Peptide Substrate | ERMRPRKRQGSVRRRV | 
| Protirelin Acetate | {pGlu}-HP-NH2 | 
| PrP 106-126 | KTNMKHMAGAAAAGAVVGGLG | 
| PSA1 141-150 | FLTPKKLQCV | 
| PTD-p65-P1 Peptide | DRQIKIWFQNRRMKWKKQLRRPSDRELSE | 
| PUMA BH3 | EEQWAREIGAQLRRMADDLNAQYER | 
| QKRPSQRSKYL | QKRPSQRSKYL | 
| QL9 | QLSPFPFDL | 
| R15K, HIV-1 Inhibitory Peptide | RIQRGPGRAFVTIGK | 
| Rabies Virus Glycoprotein (RVG29) | YTIWMPENPRPGTPCDIFTNSRGKRASNG | 
| Rat CGRP-(8-37) | VTHRLAGLLSRSGGVVKDNFVPTNVGSEAF-NH2 | 
| RC-160 (Vapreotide) | fCYwKVCW-NH2 (C2&C7 bridge) | 
| RC-3095 | XQWAVGHLL-NH2 | 
| RC-3095 (TFA) | Xaa-Gln-Trp-Ala-Val-Gly-His-Leu-Leu-NH2 | 
| ReACp53 | HRRRRRRRRRRPILTRITLE-OH | 
| Renin Substrate Tetradecapeptide, rat | DRVYIHPFHLLYYS | 
| RGD | RGD | 
| RGD peptide GRGDNP | GRGDNP | 
| RGDS | Arg-Gly-Glu-Ser(TFA) | 
| rGHRH(1-29)NH2 | HADAIFTSSYRRILGQLYARKLLHEIMNR | 
| Rhodopsin Epitope Tag | TETSQVAPA | 
| Risuteganib | GRG-{Cya}-TP | 
| RNAIII-inhibiting peptide(TFA) | YSPWTNF | 
| RREEETEEE | RREEETEEE | 
| RR-SRC | RRLIEDAEYAARG | 
| Rusalatide acetate | AGYKPDEGKR GDACEGDSGG PFV-NH2 | 
| S Tag Peptide | KETAAAKFERQHMDS | 
| S6-1 | RRLSSLRA | 
| S961 | GSLDESFYDWFERQLGGGSGGSSLEEEWAQIQCEVWGRGCPSY (Disulfide bridge: Cys33-Cys40) | 
| Sakamototide substrate peptide TFA | ALNRTSSDSALHRRR | 
| SAMS | HMRSAMSGLHLVKRR-NH2 | 
| Scrambled TRAP Fragment | FSLLRN-NH2 | 
| Scyliorhinin II | SPSNSKCPDGPDCFVGLM-NH2 | 
| SDV-Exendin-3/4 | SDVSKQMEEEAVRLFIEWLKNGGPSSGAPPPS | 
| SEB Domain 144-153 | KKKVTAQELD | 
| Secretin (5-27), porcine | TFTSELSRLRDSARLQRLLQGLV-NH2 | 
| Secretin, canine | HSDGTFTSELSRLRESARLQRLLQGLV-NH2 | 
| Secretin, human | HSDGTFTSELSRLREGARLQRLLQGLV-NH2 | 
| Secretin, porcine | HSDGTFTSELSRLRDSARLQRLLQGLV-NH2 | 
| Secretin, rat | HSDGTFTSELSRLQDSARLQRLLQGLV-NH2 | 
| Secretoneurin, rat | TNEIVEEQYTPQSLATLESVFQELGKLTGPSNQ | 
| Selank | TKPRPGP | 
| Ser25] Protein Kinase C (19-31) | RFARKGSLRQKNV | 
| sgp91 ds-tat Peptide 2, scrambled | RKKRRQRRRCLRITRQSR-NH2 | 
| Sincalide | D-{SO3H-Tyr}-MGWMDF-NH2 | 
| SIYRY | SIYRYYGL | 
| SLLK, Control Peptide for TSP1 Inhibitor | SLLK-NH2 | 
| Small Cardioactive Peptide B SCPB | MNYLAFPRM-NH2 | 
| SMCY (950-960) (human) | SPSVDKARAEL | 
| Smcy HY Peptide 738-746 | KCSRNRQYL | 
| SNAP-25 187-203 | Ac-SNKTRIDEANQRATKML-NH2 | 
| Somatostatin 28 (1-14) | SANSNPAMAPRERK | 
| Somatostatin1-14 | AGCKNFFWKTFTSC (C3&C14 bridge) | 
| Somatostatin-25 | SNPAMAPRERKAGCKNFFWKTFTSC (Disulfide bridge: Cys14-Cys25) | 
| Somatostatin-28 1-12 | SANSNPAMAPRE | 
| SPACE peptide | ACTGSTQHQCG (Disulfide bridge: Cys2-Cys10) | 
| Speract | GFDLNGGGVG | 
| Sphistin Synthetic Peptide(12-38,Fitc in N-Terminal-Fluorescently Labeled Peptide) | FITC-KAKAKAVSRSARAGLQFPVGRIHRHLK | 
| ß-Amyloid (25-35) | NH2-GSNKGAIIGLM-COOH | 
| Substance P (1-9) | RPKPQQFFG | 
| Substance P (7-11) | FFGLM-NH2 | 
| Substance P 1-7 | RPKPQQF | 
| Substance P, Free Acid | RPKPQQFFGLM | 
| Substrate for Tyrosine Protein Kinase | RRLIEDNEYTARG | 
| Suc-Leu-Leu-Val-Tyr-AMC | Suc-Leu-Leu-Val-Tyr-AMC | 
| Super-TDU (1-31) TFA | SVDDHFAKSLGDTWLQIGGSGNPKTANVPQT | 
| Super-TDU (TFA) | SVDDHFAKSLGDTWLQIGGSGNPKTANVPQTVPMRLRKLPDSFFKPPE | 
| SV40 large T antigen NLS | CGGGPKKKRKVED | 
| SV40 T-Ag-derived NLS peptide | PKKKRKVEDPYC | 
| Syntide 2 | PLARTLSVAGLPGKK | 
| SYSMEHFRWGKPS | SYSMEHFRWGKPS | 
| Systemin | AVQSKPPSKRDPPKMQTD | 
| T7 Tag Peptide | MASMTGGQQMG | 
| TAK-448 acetate | Ac-Y-{Hyp}-NTFGLRW-NH2 | 
| TAT | YGRKKRRQRRR-NH2 | 
| TAT 2-4 | YGRKKRRQRRRGYGRKKRRQRRRG | 
| TAT 48-57 | GRKKRRQRRR | 
| TAT peptide | GRKKRRQRRRPQ | 
| TB500 | Ac-LKKTETQ | 
| Tetanus toxin 830-843 | QYIKANSKFIGITE | 
| TFLLR-NH2(TFA) | TFLLR-NH2 | 
| Thioredoxin reductase peptide | WGLGGTCVNVGCIPK | 
| Thrombin Receptor Activator for Peptide 5 TRAP-5 | SFLLR | 
| Thymalfasin | Ac-SDAAVDTSSEITTKDLKEKKEVVEEAEN | 
| Thymopentin | RKDVY | 
| Thymopoietin II (32-34) | RKD | 
| Thymopoietin II (32-35) | RKDV | 
| Thyrotropin-Releasing Hormone (TRH), Free Acid | {pGlu}-HP | 
| TIP 39, Tuberoinfundibular Neuropeptide | SLALADDAAFRERARLLAALERRHWLNSYMHKLLVLDAP | 
| Tirzepatide | Y-{Aib}-EGTFTSDYSI-{Aib}-LDKIAQ-{diacid-gamma-Glu-(AEEA)2-Lys}-AFVQWLIAGGPSSGAPPPS-NH2 | 
| TLQP-30 | TLQPPASSRRRHFHHALPPARHHPDLEAQA | 
| TNF-α (10-36), human | DKPVAHVVANPQAEGQLQWLNRRANAL | 
| TNF-α (31-45), human TFA | RRANALLANGVELRD | 
| TNF-α (46-65), human | NQLVVPSEGLYLIYSQVLFK | 
| Tos-Gly-Pro-Arg-ANBA-IPA acetate | Tos-GPR-ANBA-IPA | 
| TP508 | AGYKPDEGKRGDACEGDSGGPFV | 
| Transportan | GWTLNSAGYLLGKINLKALAALAKKIL-NH2 | 
| Trp-Asn-Arg-Gln-Leu-Tyr-Pro-Glu-Trp-Thr-Glu-Ala-Gln-Arg-Leu-Asp | WNRQLYPEWTEAQRLD | 
| Tuftsin | TKPR | 
| Tyr-Ile-Tyr-Gly-Ser-Phe-Lys | YIYGSFK | 
| Tyrosinase (192-200), human mouse | SEIWRDIDF | 
| Tyrosinase (206-214), human | AFLPWHRLF | 
| Tyrosine Protein Kinase JAK 2 Phospho-Tyr8, 9 | VLPQDKE-{pTyr}{pTyr}-KVKEPGE | 
| Tyr-Somatostatin-14 | YAGCKNFFWKTFTSC (Disulfide bridge: Cys4-Cys15) | 
| Urechistachykinin I | LRQSQFVGSR-NH2 | 
| Urechistachykinin II | AAGMGFFGAR-NH2 | 
| Urocortin II, human | IVLSLDVPIGLLQILLEQARARAAREQATTNARILARVGHC-NH2 | 
| Urocortin III, human | FTLSLDVPTNIMNLLFNIAKAKNLRAQAAANAHLMAQI-NH2 | 
| Urocortin III, mouse | FTLSLDVPTNIMNILFNIDKAKNLRAKAAANAQLMAQI-NH2 | 
| Urocortin III, mouse, free acid | FTLSLDVPTNIMNILFNIDKAKNLRAKAAANAQLMAQI | 
| Urocortin, human | DNPSLSIDLTFHLLRTLLELARTQSQRERAEQNRIIFDSV-NH2 | 
| Urocortin, rat | DDPPLSIDLTFHLLRTLLELARTQSQRERAEQNRIIFDSV-NH2 | 
| Urotensin I | NDDPPISIDLTFHLLRNMIEMARIENEREQAGLNRKYLDEV-NH2 | 
| Urotensin II (114-124), human | ETPDCFWKYCV (Disulfide bridge: Cys5-Cys7) | 
| Urotensin II, mouse | {pGlu}-HGAAPECFWKYCI (Disulfide bridge: Cys8-Cys13) | 
| Uty HY Peptide 246-254 | WMHHNMDLI | 
| V5 Epitope Tag Peptide Trifluoroacetate | GKPIPNPLLGLDST | 
| Vasonatrin Peptide VNP | GLSKGCFGLKLDRIGSMSGLGCNSFRY (Disulfide bridge: Cys6-Cys22) | 
| VIP(6-28)(human, rat, porcine, bovine) | FTDNYTRLRKQMAVKKYLNSILN-NH2 | 
| VIP, guinea pig | HSDALFTDTYTRLRKQMAMKKYLNSVLN-NH2 | 
| VIP, human, porcine, rat, ovine | HSDAVFTDNYTRLRKQMAVKKYLNSILN-NH2 | 
| VIR-165 | LEAIPCSIPPCFAFNKPFVF (Disulfide bridge: Cys6-Cys11) | 
| VSV-G Peptide | YTDIEMNRLGK | 
| WKYMVM | WKYMV-{d-Met} | 
| WKYMVM TFA | WKYMVM-NH2 | 
| Xenin | MLTKFETKSARVKGLSFHPKRPWIL | 
| Xenopsin | {Glp}-GKRPWIL | 
| X-press Tag Peptide | DLYDDDDK | 
| YRGDS Fibronectin Fragment | YRGDS | 
| Z-Gly-Gly-Arg-AMC | ZGGR-AMC | 
| Z-VRPR-FMK (TFA) | Z-VRPR-FMK | 
| α2β1 Integrin Ligand Peptide | DGEA | 
| α-Bag Cell Peptide (1-7) | APRLRFY | 
| α-Bag Cell Peptide (1-8) | APRLRFYS | 
| α-Bag Cell Peptide (1-9) | APRLRFYSL | 
| α-Casein 90-95 | RYLGYL | 
| α-Factor Mating Pheromone, yeast | WHWLQLKPGQPMY | 
| α-Melanocyte-Stimulating Hormone (MSH), amide(α-MSH) | Ac-SYSMEHFRWGKPV-NH2 | 
| α-MSH | Ac-SYSMEHFRWGKPV-CONH2 | 
| α-Neoendorphin 1-8 | YGGFLRKY | 
| β-Amyloid (1-10) | DAEFRHDSGY | 
| β-Amyloid (1-11) | DAEFRHDSGYE | 
| β-Amyloid (1-12) | DAEFRHDSGYEV | 
| β-Amyloid (1-13) | DAEFRHDSGYEVH | 
| β-Amyloid (1-14) | DAEFRHDSGYEVHH | 
| β-Amyloid (1-18) | DAEFRHDSGYEVHHQKLV | 
| β-Amyloid (1-20) | DAEFRHDSGYEVHHQKLVFF | 
| β-Amyloid (1-28) | DAEFRHDSGYEVHHQKLVFFAEDVGSNK | 
| β-Amyloid (1-40) | DAEFRHDSGYEVHHQKLVFFAEDVGSNKGAIIGLMVGGVV | 
| β-Amyloid (1-42), human | DAEFRHDSGYEVHHQKLVFFAEDVGSNKGAIIGLMVGGVVIA | 
| β-Amyloid (1-42), rat | DAEFGHDSGFEVRHQKLVFFAEDVGSNKGAIIGLMVGGVVIA | 
| β-Amyloid (1-9) | DAEFRHDSG | 
| β-Amyloid (25-35) | GSNKGAIIGLM | 
| β-Amyloid 12-20 | VHHQKLVFF | 
| β-Amyloid 4-10 | FRHDSGY | 
| β-Bag Cell Factor | RLRFH | 
| β-Casomorphin (1-3), amide | YPF-NH2 | 
| β-Casomorphin (1-5), amide, bovine | Y-{d-Ala}-FPM-NH2 | 
| β-Casomorphin (1-5), bovine | YPFPG | 
| β-Casomorphin (1-6), bovine | YPFPGP | 
| β-Casomorphin, bovine | YPFPGPI | 
| β-Casomorphin, human | YPFVEPI | 
| β-catenin peptide | RTYTYEKL | 
| β-CGRP, human TFA | ACNTATCVTHRLAGLLSRSGGMVKSNFVPTNVGSKAF-NH2(Disulfide bridge: Cys2-Cys7) | 
| β-Endorphin, equine | YGGFMSSEKSQTPLVTLFKNAIIKNAHKKGQ | 
| β-Melanocyte Stimulating Hormone (MSH), human TFA | AEKKDEGPYRMEHFRWGSPPKD | 
| γ-1-Melanocyte Stimulating Hormone (MSH), amide | YVMGHFRWDRF-NH2 | 
| γ-2-MSH (41-58), amide | YVMGHFRWDRFG-NH2 | 
| γ-Bag Cell Factor | RLRFD | 
| γ-Glu-Phe | γ-Glu-Phe |